Advertisement
Screener

GEOVAX LABS, INC. (GOVX) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

GEOVAX LABS, INC. Research and Development Expense

GEOVAX LABS, INC. (GOVX) reported Research and Development Expense of $3.11 million for the 3-month period ending 2026-06-30, per its S-1 filed 2026-09-17.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-09-17

  • GEOVAX LABS, INC. research and development expense for the quarter ending 2026-06-30 was $3.11M, a 34.22% decline year-over-year.
  • GEOVAX LABS, INC. research and development expense for the quarter ending 2026-03-31 was $3.90M, a 27.10% decline year-over-year.
  • GEOVAX LABS, INC. research and development expense for the quarter ending 2025-12-31 was $2.99M, a 60.64% decline year-over-year.
  • GEOVAX LABS, INC. research and development expense for the quarter ending 2025-09-30 was $5.04M, a 31.87% decline year-over-year.
  • GEOVAX LABS, INC. research and development expense for fiscal 2023 was $20.72M, a 127.11% increase from fiscal 2022.
  • GEOVAX LABS, INC. research and development expense for fiscal 2022 was $9.12M, a 41.34% decline from fiscal 2021.
  • GEOVAX LABS, INC. research and development expense for fiscal 2021 was $15.55M, a 536.30% increase from fiscal 2020.
  • GEOVAX LABS, INC. research and development expense for fiscal 2020 was $2.44M, a 27.93% increase from fiscal 2019.
Period endResearch and Development Expense 3 monthResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 monthResearch and Development Expense 120 monthResearch and Development Expense 123 monthResearch and Development Expense 126 monthResearch and Development Expense 129 monthResearch and Development Expense 132 monthResearch and Development Expense 135 monthResearch and Development Expense 138 monthResearch and Development Expense 141 monthResearch and Development Expense 144 monthResearch and Development Expense 147 monthResearch and Development Expense 150 monthResearch and Development Expense 153 month
2026-06-30$3.11M
S-1 · filed 2026-09-17
$7.01M
S-1 · filed 2026-09-17
$10.01M
derived: sum of 3 quarters · filed 2026-09-17
$15.05M
derived: sum of 4 quarters · filed 2026-09-17
2026-03-31$3.90M
10-Q · filed 2026-05-14
$6.90M
derived: sum of 2 quarters · filed 2026-09-17
$11.94M
derived: sum of 3 quarters · filed 2026-09-17
$16.67M
derived: sum of 4 quarters · filed 2026-09-17
2025-12-31$2.99M
derived: S-1 12 month − 10-Q 9 month · filed 2026-09-17
$8.04M
derived: sum of 2 quarters · filed 2026-09-17
$12.77M
derived: sum of 3 quarters · filed 2026-09-17
$18.12M
S-1 · filed 2026-09-17
2025-09-30$5.04M
10-Q · filed 2025-11-13
$9.77M
derived: sum of 2 quarters · filed 2026-09-17
$15.13M
10-Q · filed 2025-11-13
$22.74M
derived: sum of 4 quarters · filed 2026-09-17
2025-06-30$4.73M
S-1 · filed 2026-09-17
$10.08M
S-1 · filed 2026-09-17
$17.69M
derived: sum of 3 quarters · filed 2026-09-17
$25.09M
derived: sum of 4 quarters · filed 2026-09-17
2025-03-31$5.35M
10-Q · filed 2026-05-14
$12.96M
derived: sum of 2 quarters · filed 2026-09-17
$20.37M
derived: sum of 3 quarters · filed 2026-09-17
$24.64M
derived: sum of 4 quarters · filed 2026-09-17
2024-12-31$7.61M
derived: S-1 12 month − 10-Q 9 month · filed 2026-09-17
$15.01M
derived: sum of 2 quarters · filed 2026-09-17
$19.29M
derived: sum of 3 quarters · filed 2026-09-17
$23.71M
S-1 · filed 2026-09-17
2024-09-30$7.40M
10-Q · filed 2025-11-13
$11.68M
derived: sum of 2 quarters · filed 2025-11-13
$16.11M
10-Q · filed 2025-11-13
$22.34M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$4.28M
10-Q · filed 2025-07-28
$8.70M
10-Q · filed 2025-07-28
$14.94M
derived: sum of 3 quarters · filed 2025-07-28
$21.88M
derived: sum of 4 quarters · filed 2025-07-28
2024-03-31$4.43M
10-Q · filed 2025-05-01
$10.66M
derived: sum of 2 quarters · filed 2025-05-01
$17.61M
derived: sum of 3 quarters · filed 2025-05-01
$22.33M
derived: sum of 4 quarters · filed 2025-05-01
2023-12-31$6.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
$13.18M
derived: sum of 2 quarters · filed 2025-03-27
$17.90M
derived: sum of 3 quarters · filed 2025-03-27
$20.72M
10-K · filed 2025-03-27
2023-09-30$6.95M
10-Q · filed 2024-11-12
$11.67M
derived: sum of 2 quarters · filed 2024-11-12
$14.49M
10-Q · filed 2024-11-12
$18.25M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30$4.72M
10-Q · filed 2024-08-06
$7.54M
10-Q · filed 2024-08-06
$11.30M
derived: sum of 3 quarters · filed 2024-08-06
$14.02M
derived: sum of 4 quarters · filed 2024-08-06
2023-03-31$2.82M
10-Q · filed 2024-05-14
$6.58M
derived: sum of 2 quarters · filed 2024-05-14
$9.30M
derived: sum of 3 quarters · filed 2024-05-14
$10.61M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$3.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$6.49M
derived: sum of 2 quarters · filed 2024-02-29
$7.79M
derived: sum of 3 quarters · filed 2024-02-29
$9.12M
10-K · filed 2024-02-29
2022-09-30$2.72M
10-Q · filed 2023-11-08
$4.03M
derived: sum of 2 quarters · filed 2023-11-08
$5.36M
10-Q · filed 2023-11-08
$18.25M
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30$1.31M
10-Q · filed 2023-08-09
$2.64M
10-Q · filed 2023-08-09
$15.53M
derived: sum of 3 quarters · filed 2023-08-09
$16.76M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$1.33M
10-Q · filed 2023-05-04
$14.22M
derived: sum of 2 quarters · filed 2023-05-04
$15.45M
derived: sum of 3 quarters · filed 2023-05-04
$16.28M
derived: sum of 4 quarters · filed 2023-05-04
2021-12-31$12.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
$14.12M
derived: sum of 2 quarters · filed 2023-03-23
$14.95M
derived: sum of 3 quarters · filed 2023-03-23
$15.55M
10-K · filed 2023-03-23
2021-09-30$1.22M
10-Q · filed 2022-11-09
$2.06M
derived: sum of 2 quarters · filed 2022-11-09
$2.66M
10-Q · filed 2022-11-09
$3.42M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$832.84K
10-Q · filed 2022-08-03
$1.44M
10-Q · filed 2022-08-03
$2.19M
derived: sum of 3 quarters · filed 2022-08-03
$2.61M
derived: sum of 4 quarters · filed 2022-08-03
2021-03-31$602.78K
10-Q · filed 2022-04-27
$1.36M
derived: sum of 2 quarters · filed 2022-04-27
$1.78M
derived: sum of 3 quarters · filed 2022-04-27
$2.24M
derived: sum of 4 quarters · filed 2022-04-27
2020-12-31$757.35K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09
$1.17M
derived: sum of 2 quarters · filed 2022-03-09
$1.64M
derived: sum of 3 quarters · filed 2022-03-09
$2.44M
10-K · filed 2022-03-09
2020-09-30$416.76K
10-Q · filed 2021-11-12
$878.18K
derived: sum of 2 quarters · filed 2021-11-12
$1.69M
10-Q · filed 2021-11-12
$2.12M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$461.42K
10-Q · filed 2021-08-11
$1.27M
10-Q · filed 2021-08-11
$1.71M
derived: sum of 3 quarters · filed 2021-08-11
$2.17M
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31$808.94K
10-Q · filed 2021-05-06
$1.25M
derived: sum of 2 quarters · filed 2021-05-06
$1.71M
derived: sum of 3 quarters · filed 2021-05-06
$2.16M
derived: sum of 4 quarters · filed 2021-05-06
2019-12-31$436.10K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23
$903.77K
derived: sum of 2 quarters · filed 2021-03-23
$1.35M
derived: sum of 3 quarters · filed 2021-03-23
$1.91M
10-K · filed 2021-03-23
2019-09-30$467.67K
10-Q · filed 2020-11-05
$918.90K
derived: sum of 2 quarters · filed 2020-11-05
$1.47M
10-Q · filed 2020-11-05
$1.94M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30$451.23K
10-Q · filed 2020-08-10
$1.01M
10-Q · filed 2020-08-10
$1.47M
derived: sum of 3 quarters · filed 2020-08-10
$2.03M
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31$555.72K
10-Q · filed 2020-05-05
$1.02M
derived: sum of 2 quarters · filed 2020-05-05
$1.58M
derived: sum of 3 quarters · filed 2020-05-05
$1.95M
derived: sum of 4 quarters · filed 2020-05-05
2018-12-31$461.76K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24
$1.02M
derived: sum of 2 quarters · filed 2020-03-24
$1.39M
derived: sum of 3 quarters · filed 2020-03-24
$1.88M
10-K · filed 2020-03-24
2018-09-30$557.70K
10-Q · filed 2019-11-07
$929.90K
derived: sum of 2 quarters · filed 2019-11-07
$1.42M
10-Q · filed 2019-11-07
$1.87M
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30$372.20K
10-Q · filed 2019-08-13
$859.20K
10-Q · filed 2019-08-13
$1.31M
derived: sum of 3 quarters · filed 2019-08-13
$1.81M
derived: sum of 4 quarters · filed 2019-08-13
2018-03-31$486.99K
10-Q · filed 2019-05-13
$936.25K
derived: sum of 2 quarters · filed 2019-05-13
$1.43M
derived: sum of 3 quarters · filed 2019-05-13
$1.95M
derived: sum of 4 quarters · filed 2019-05-13
2017-12-31$449.26K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26
$947.46K
derived: sum of 2 quarters · filed 2019-03-26
$1.47M
derived: sum of 3 quarters · filed 2019-03-26
$2.02M
10-K · filed 2019-03-26
2017-09-30$498.20K
10-Q · filed 2018-11-08
$1.02M
derived: sum of 2 quarters · filed 2018-11-08
$1.57M
10-Q · filed 2018-11-08
$2.02M
derived: sum of 4 quarters · filed 2019-03-26
2017-06-30$518.10K
10-Q · filed 2018-08-07
$1.07M
10-Q · filed 2018-08-07
$1.52M
derived: sum of 3 quarters · filed 2019-03-26
$2.21M
derived: sum of 4 quarters · filed 2019-03-26
2017-03-31$551.79K
10-Q · filed 2018-05-03
$1.00M
derived: sum of 2 quarters · filed 2019-03-26
$1.69M
derived: sum of 3 quarters · filed 2019-03-26
$2.08M
derived: sum of 4 quarters · filed 2019-03-26
2016-12-31$451.34K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26
$1.14M
derived: sum of 2 quarters · filed 2019-03-26
$1.53M
derived: sum of 3 quarters · filed 2019-03-26
$1.97M
10-K · filed 2019-03-26
2016-09-30$683.94K
10-Q · filed 2017-11-09
$1.08M
derived: sum of 2 quarters · filed 2017-11-09
$1.52M
10-Q · filed 2017-11-09
$2.05M
derived: sum of 4 quarters · filed 2018-03-23
2016-06-30$397.58K
10-Q · filed 2017-08-14
$835.58K
10-Q · filed 2017-08-14
$1.36M
derived: sum of 3 quarters · filed 2018-03-23
$1.74M
derived: sum of 4 quarters · filed 2018-03-23
2016-03-31$438.00K
10-Q · filed 2017-05-12
$964.30K
derived: sum of 2 quarters · filed 2018-03-23
$1.34M
derived: sum of 3 quarters · filed 2018-03-23
$1.73M
derived: sum of 4 quarters · filed 2018-03-23
2015-12-31$526.30K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23
$904.82K
derived: sum of 2 quarters · filed 2018-03-23
$1.29M
derived: sum of 3 quarters · filed 2018-03-23
$1.69M
10-K · filed 2018-03-23
2015-09-30$378.52K
10-Q · filed 2016-11-14
$763.17K
derived: sum of 2 quarters · filed 2016-11-14
$1.17M
10-Q · filed 2016-11-14
$1.64M
derived: sum of 4 quarters · filed 2017-03-24
2015-06-30$384.65K
10-Q · filed 2016-08-05
$788.28K
10-Q · filed 2016-08-05
$1.26M
derived: sum of 3 quarters · filed 2017-03-24
$1.68M
derived: sum of 4 quarters · filed 2017-03-24
2015-03-31$403.63K
10-Q · filed 2016-05-04
$872.04K
derived: sum of 2 quarters · filed 2017-03-24
$1.30M
derived: sum of 3 quarters · filed 2017-03-24
$1.81M
derived: sum of 4 quarters · filed 2017-03-24
2014-12-31$468.41K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24
$893.91K
derived: sum of 2 quarters · filed 2017-03-24
$1.41M
derived: sum of 3 quarters · filed 2017-03-24
$1.81M
10-K · filed 2017-03-24
2014-09-30$425.50K
10-Q · filed 2015-11-12
$941.70K
derived: sum of 2 quarters · filed 2015-11-12
$1.34M
10-Q · filed 2015-11-12
$1.95M
derived: sum of 4 quarters · filed 2016-03-16
2014-06-30$516.20K
10-Q · filed 2015-08-04
$919.06K
10-Q · filed 2015-08-04
$1.52M
derived: sum of 3 quarters · filed 2016-03-16
$2.40M
derived: sum of 4 quarters · filed 2016-03-16
2014-03-31$402.86K
10-Q · filed 2014-05-02
$1.00M
derived: sum of 2 quarters · filed 2016-03-16
$1.88M
derived: sum of 3 quarters · filed 2016-03-16
$2.44M
derived: sum of 4 quarters · filed 2016-03-16
$31.99M
10-Q · filed 2014-05-02
2013-12-31$600.59K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16
$1.48M
derived: sum of 2 quarters · filed 2016-03-16
$2.03M
derived: sum of 3 quarters · filed 2016-03-16
$2.91M
10-K · filed 2016-03-16
$31.59M
10-K · filed 2014-03-14
2013-09-30$879.10K
10-Q · filed 2014-11-12
$1.43M
derived: sum of 2 quarters · filed 2014-11-12
$2.31M
10-Q · filed 2014-11-12
$2.97M
derived: sum of 4 quarters · filed 2015-03-20
$30.99M
10-Q · filed 2013-11-12
2013-06-30$553.20K
10-Q · filed 2014-08-08
$1.44M
10-Q · filed 2014-08-08
$2.09M
derived: sum of 3 quarters · filed 2015-03-20
$2.69M
derived: sum of 4 quarters · filed 2015-03-20
$30.11M
10-Q · filed 2013-08-12
2013-03-31$881.99K
10-Q · filed 2014-05-02
$1.54M
derived: sum of 2 quarters · filed 2015-03-20
$2.14M
derived: sum of 3 quarters · filed 2015-03-20
$2.85M
derived: sum of 4 quarters · filed 2015-03-20
$29.56M
10-Q · filed 2013-05-01
2012-12-31$657.06K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-20
$1.26M
derived: sum of 2 quarters · filed 2015-03-20
$1.97M
derived: sum of 3 quarters · filed 2015-03-20
$3.04M
10-K · filed 2015-03-20
$28.67M
10-K · filed 2013-03-18
2012-09-30$601.69K
10-Q · filed 2013-11-12
$1.31M
derived: sum of 2 quarters · filed 2013-11-12
$2.39M
10-Q · filed 2013-11-12
$3.35M
derived: sum of 4 quarters · filed 2014-03-14
$28.02M
10-Q · filed 2012-11-13
2012-06-30$712.42K
10-Q · filed 2013-08-12
$1.78M
10-Q · filed 2013-08-12
$2.75M
derived: sum of 3 quarters · filed 2014-03-14
$3.84M
derived: sum of 4 quarters · filed 2014-03-14
$27.42M
10-Q · filed 2012-08-13
2012-03-31$1.07M
10-Q · filed 2013-05-01
$2.03M
derived: sum of 2 quarters · filed 2014-03-14
$3.12M
derived: sum of 3 quarters · filed 2014-03-14
$4.51M
derived: sum of 4 quarters · filed 2014-03-14
$26.70M
10-Q · filed 2012-05-14
2011-12-31$962.52K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14
$2.05M
derived: sum of 2 quarters · filed 2014-03-14
$3.44M
derived: sum of 3 quarters · filed 2014-03-14
$4.28M
10-K · filed 2014-03-14
$25.63M
10-K · filed 2012-03-30
2011-09-30$1.09M
10-Q · filed 2012-11-13
$2.48M
derived: sum of 2 quarters · filed 2012-11-13
$3.31M
10-Q · filed 2012-11-13
$4.09M
derived: sum of 4 quarters · filed 2013-03-18
$24.67M
10-Q · filed 2011-11-10
2011-06-30$1.39M
10-Q · filed 2012-08-13
$2.22M
10-Q · filed 2012-08-13
$3.00M
derived: sum of 3 quarters · filed 2013-03-18
$3.91M
derived: sum of 4 quarters · filed 2013-03-18
$23.58M
10-Q · filed 2011-08-12
2011-03-31$838.47K
10-Q · filed 2012-05-14
$1.61M
derived: sum of 2 quarters · filed 2013-03-18
$2.52M
derived: sum of 3 quarters · filed 2013-03-18
$4.26M
derived: sum of 4 quarters · filed 2013-03-18
2010-12-31$774.02K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$1.68M
derived: sum of 2 quarters · filed 2013-03-18
$3.42M
derived: sum of 3 quarters · filed 2013-03-18
$4.79M
10-K · filed 2013-03-18
2010-09-30$908.78K
10-Q · filed 2011-11-10
$2.65M
derived: sum of 2 quarters · filed 2011-11-10
$4.02M
10-Q · filed 2011-11-10
2010-06-30$1.74M
10-Q · filed 2011-08-12
$3.11M
10-Q · filed 2011-08-12
2009-12-31$4.07M
10-K · filed 2012-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Genprex, Inc. (GNPX)United States$0.003B-0.02
Alaunos Therapeutics, Inc. (TCRT)United States$0.003B-1.44
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
Sunshine Biopharma Inc. (SBFM)$0.003B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
ORAGENICS INC (OGEN)United States$0.002B